Whitehawk Therapeutics Financial Overview
Whitehawk Therapeutics's market cap is currently $114.05M. The company's EPS TTM is $-0.26; its P/E ratio is 17.82; Whitehawk Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
